About One Lambda
One Lambda is a company based in Los Angeles (United States) founded in 1984 was acquired by Thermo Fisher Scientific in July 2012. One Lambda offers products and services including HLA Typing, Antibody Detection, Molecular Assays, Blood Screening, and Software. One Lambda operates in a competitive market with competitors including Oxford Immunotec, Mirvie, DotLab, Syrona Health and GenDx, among others.
- Headquarter Los Angeles, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website onelambda.com
- Social LinkedIn X
- Acquired by Thermo Fisher Scientific (Jul 2012)
- Legal Name Thermo Fisher Scientific Inc.
- Investors
- Acquired byThermo Fisher Scientific
(Jul 2012)
Products & Services of One Lambda
One Lambda offers a comprehensive portfolio of products and services, including HLA Typing, Antibody Detection, Molecular Assays, Blood Screening, and Software.
Service for human leukocyte antigen identification and testing
Tools for monitoring and detecting antibodies in samples
Assays for genetic and molecular analysis services
Methods for screening and typing blood components
Platform for accessing product documentation and support
Investors in One Lambda
One Lambda has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for One Lambda
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of One Lambda
2 dated milestones of One Lambda across 28 years, from founding to its latest funding, stage changes and deals.
- Founded One Lambda is founded.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of One Lambda
One Lambda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Immunotec, Mirvie, DotLab, Syrona Health and GenDx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oxfordimmunotec.com | 2002 | Abingdon, United Kingdom | $94M | 184 | Immune markers are utilized by Oxford Immunotec for disease diagnostics. | |
| mirvie.com | 2019 | San Francisco, United States | $113.7M | 35 | Non-invasive blood tests for prenatal fetal health predictions are offered. | |
| dotlab.com | 2016 | Branford, United States | $10M | 11 | Molecular diagnostic testing for endometriosis is provided via saliva-based biomarkers. | |
| syronahealth.com | 2018 | Newcastle Upon Tyne, United Kingdom | $199,744 | 5 | Digital women's health management software for employers and individuals | |
| gendx.com | 2005 | Utrecht, Netherlands | – | – | Develops and markets a line of In Vitro Diagnostic (IVD) tests and services, analysis software and education | |
| immucor.com | 1982 | United States | – | 44 | Transfusion and transplantation diagnostic products are provided by Immucor. | |
| provistadx.com | 2007 | New York, United States | $41.75M | 2 | Blood-based diagnostic tests for early women's cancer detection are developed. | |
| transplantgenomics.com | 2013 | Los Angeles, United States | $20.6M | – | Molecular diagnostic tests for early graft injury detection are developed. | |
| myolaris.com | 2014 | Waltham, United States | $62,500 | 9 | In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration. |
Detailed competitors of One Lambda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of One Lambda
Websites that share an audience with One Lambda (onelambda.com).
Websites whose visitors overlap most with One Lambda. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gendx.com | 100% | 13.7K | #2,283,053 | View details | |
| tepnel.com | 88% | – | – | View details | |
| ckdpharm.com | 88% | 89.5K | #398,415 | View details | |
| donga.co.kr | 88% | 17.1K | #1,381,945 | View details | |
| astellas.com | 88% | 170.7K | #288,207 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for One Lambda
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on One Lambda
Complete news archive for One Lambda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to One Lambda
10 companies that operate in the same segment as One Lambda (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about One Lambda
One Lambda was founded in 1984.
One Lambda is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
One Lambda was founded in 1984 in Los Angeles, United States, and operates in the transplant diagnostics sector. A portfolio of products is maintained, including bead-based multiplexing assays for PRA screening, AT1R and ETAR antibody detection, FlowPRA assays using flow cytometry, ELISA-based HLA IgG antibody tests, Lambda antigen and cell trays. Molecular tools such as next-generation sequencing, sequence-based typing, real-time PCR, and sequence-specific primers are also provided.
One Lambda's top competitors include Mirvie, Olaris and Syrona Health.
One Lambda offers HLA Typing, Antibody Detection, Molecular Assays, Blood Screening, and Software.
One Lambda has 1 investor. Key investors include Thermo Fisher Scientific.
One Lambda operates through Thermo Fisher Scientific Inc..
Yes. One Lambda was acquired by Thermo Fisher Scientific in July 2012.